Global Cannabidiol (CBD)

Cannabidiol (CBD) Comprehensive Study by Application (Personal Care & Cosmetics, Pharmaceutical, Food & Beverages, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, Others), Product (Cannabis Balm, Cannabis Cream, Cannabis Oil, Cannabis Oil Capsules, Others), Source (Hemp, Marijuana) Players and Region - MEA Market Outlook to 2026

Cannabidiol (CBD) Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Cannabidiol (CBD) Market Scope?
Cannabis is a drug that comes from Indian hemp plants including Cannabis sativa and Cannabis indica. South Africa, cannabis production and distribution has booming. Cannabis is majorly adopted for many recreational used in various forms including ingested in teas, sodas, baked goods and also in vaporizing form. The cannabis is applied to multiple consumer goods such as carbonated beverages, coffee, alcohol, tobacco, and other packaged goods. The cultivation, production, and manufacturing of Cannabis products for medicinal use in South Africa. South Africa minimizes the risk of diversion of Cannabis and reserves its use for medical and scientific purposes only with the help of the International Narcotics Drug Control Board.

The Cannabidiol (CBD) market study is being classified, by Application (Personal Care & Cosmetics, Pharmaceutical, Food & Beverages and Others) and major geographies with country level break-up.

The global CBD market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability.

Canopy Growth Corporation (Canada), Elixinol (United States), Aphria, Inc. (Canada), CannaLife (South Africa), BIOMUTI (Pty) Ltd (South Africa), NuLeaf Naturals, LLC (United States), Oil Science (South Africa), Cannaza (South Africa), CBD Biotechnologies (South Africa) and King CBD (South Africa) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of MEA Cannabidiol (CBD) market by Type, Application and Region.

On the basis of geography, the market of Cannabidiol (CBD) has been segmented into MEA (South Africa).

In Jun 2019, Applied DNA announced a partnership with TheraCann International Benchmark Corporation. That is an agreement with House of hemp, a licensed pioneer in South African fiber, seed, oil and Cannabidiol medicinal production. This agreement with HOH defined the new opportunities across an array for the ETCH platform.
In May 2019, South Africa is the first in Africa region who has federally approved for non-prescription CBD. According to the Health Minister Aaron Motsoaledi amended the country’s medicines and related substances Act 1965, on the removal of cannabidiol preparations for nonserious health claims on the recommendation of South African Health Products Regularity Authority.

Influencing Market Trend
  • Increase Government Initiatives towards Cannabis-Related Research and Development
  • Advancement in Cultivation and Production Methods

Market Drivers
  • High Demand for Cannabis-Related Pharmaceutical Products
  • Rising Geriatric Population In Need Of Treatment for Chronic Diseases
  • Growing Demand for Cannabis Testing Products from Luxury Cannabis Products

Opportunities
  • Growing South Africa Legalization of Cannabis and Hemp

Restraints
  • Fluctuation in Price and Foreign Currency Exchange Rates
  • High Cost Related Within Cannabis Testing Equipment

Challenges
  • High Initial Investments to Set Up Laboratories Are Expect To Challenge the Market
  • Stringent Regulations


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, CBD Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Personal Care & Cosmetics
  • Pharmaceutical
  • Food & Beverages
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

By Product
  • Cannabis Balm
  • Cannabis Cream
  • Cannabis Oil
  • Cannabis Oil Capsules
  • Others

By Source
  • Hemp
  • Marijuana

By Regions
  • MEA
    • South Africa
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand for Cannabis-Related Pharmaceutical Products
      • 3.2.2. Rising Geriatric Population In Need Of Treatment for Chronic Diseases
      • 3.2.3. Growing Demand for Cannabis Testing Products from Luxury Cannabis Products
    • 3.3. Market Challenges
      • 3.3.1. High Initial Investments to Set Up Laboratories Are Expect To Challenge the Market
      • 3.3.2. Stringent Regulations
    • 3.4. Market Trends
      • 3.4.1. Increase Government Initiatives towards Cannabis-Related Research and Development
      • 3.4.2. Advancement in Cultivation and Production Methods
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. MEA Cannabidiol (CBD), by Application, Distribution Channel, Product, Source and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. MEA Cannabidiol (CBD) (Value)
      • 5.2.1. MEA Cannabidiol (CBD) by: Application (Value)
        • 5.2.1.1. Personal Care & Cosmetics
        • 5.2.1.2. Pharmaceutical
        • 5.2.1.3. Food & Beverages
        • 5.2.1.4. Others
      • 5.2.2. MEA Cannabidiol (CBD) by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Stores
        • 5.2.2.4. Others
      • 5.2.3. MEA Cannabidiol (CBD) by: Product (Value)
        • 5.2.3.1. Cannabis Balm
        • 5.2.3.2. Cannabis Cream
        • 5.2.3.3. Cannabis Oil
        • 5.2.3.4. Cannabis Oil Capsules
        • 5.2.3.5. Others
      • 5.2.4. MEA Cannabidiol (CBD) by: Source (Value)
        • 5.2.4.1. Hemp
        • 5.2.4.2. Marijuana
      • 5.2.5. MEA Cannabidiol (CBD) Region
        • 5.2.5.1. MEA
          • 5.2.5.1.1. South Africa
    • 5.3. MEA Cannabidiol (CBD) (Volume)
      • 5.3.1. MEA Cannabidiol (CBD) by: Application (Volume)
        • 5.3.1.1. Personal Care & Cosmetics
        • 5.3.1.2. Pharmaceutical
        • 5.3.1.3. Food & Beverages
        • 5.3.1.4. Others
      • 5.3.2. MEA Cannabidiol (CBD) by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Stores
        • 5.3.2.4. Others
      • 5.3.3. MEA Cannabidiol (CBD) by: Product (Volume)
        • 5.3.3.1. Cannabis Balm
        • 5.3.3.2. Cannabis Cream
        • 5.3.3.3. Cannabis Oil
        • 5.3.3.4. Cannabis Oil Capsules
        • 5.3.3.5. Others
      • 5.3.4. MEA Cannabidiol (CBD) by: Source (Volume)
        • 5.3.4.1. Hemp
        • 5.3.4.2. Marijuana
      • 5.3.5. MEA Cannabidiol (CBD) Region
        • 5.3.5.1. MEA
          • 5.3.5.1.1. South Africa
    • 5.4. MEA Cannabidiol (CBD) (Price)
  • 6. Cannabidiol (CBD): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Canopy Growth Corporation (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Elixinol (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aphria, Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CannaLife (South Africa)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BIOMUTI (Pty) Ltd (South Africa)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NuLeaf Naturals, LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Oil Science (South Africa)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cannaza (South Africa)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CBD Biotechnologies (South Africa)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. King CBD (South Africa)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. MEA Cannabidiol (CBD) Sale, by Application, Distribution Channel, Product, Source and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. MEA Cannabidiol (CBD) (Value)
      • 7.2.1. MEA Cannabidiol (CBD) by: Application (Value)
        • 7.2.1.1. Personal Care & Cosmetics
        • 7.2.1.2. Pharmaceutical
        • 7.2.1.3. Food & Beverages
        • 7.2.1.4. Others
      • 7.2.2. MEA Cannabidiol (CBD) by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Stores
        • 7.2.2.4. Others
      • 7.2.3. MEA Cannabidiol (CBD) by: Product (Value)
        • 7.2.3.1. Cannabis Balm
        • 7.2.3.2. Cannabis Cream
        • 7.2.3.3. Cannabis Oil
        • 7.2.3.4. Cannabis Oil Capsules
        • 7.2.3.5. Others
      • 7.2.4. MEA Cannabidiol (CBD) by: Source (Value)
        • 7.2.4.1. Hemp
        • 7.2.4.2. Marijuana
      • 7.2.5. MEA Cannabidiol (CBD) Region
        • 7.2.5.1. MEA
          • 7.2.5.1.1. South Africa
    • 7.3. MEA Cannabidiol (CBD) (Volume)
      • 7.3.1. MEA Cannabidiol (CBD) by: Application (Volume)
        • 7.3.1.1. Personal Care & Cosmetics
        • 7.3.1.2. Pharmaceutical
        • 7.3.1.3. Food & Beverages
        • 7.3.1.4. Others
      • 7.3.2. MEA Cannabidiol (CBD) by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Stores
        • 7.3.2.4. Others
      • 7.3.3. MEA Cannabidiol (CBD) by: Product (Volume)
        • 7.3.3.1. Cannabis Balm
        • 7.3.3.2. Cannabis Cream
        • 7.3.3.3. Cannabis Oil
        • 7.3.3.4. Cannabis Oil Capsules
        • 7.3.3.5. Others
      • 7.3.4. MEA Cannabidiol (CBD) by: Source (Volume)
        • 7.3.4.1. Hemp
        • 7.3.4.2. Marijuana
      • 7.3.5. MEA Cannabidiol (CBD) Region
        • 7.3.5.1. MEA
          • 7.3.5.1.1. South Africa
    • 7.4. MEA Cannabidiol (CBD) (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cannabidiol (CBD): by Application(USD Million)
  • Table 2. Cannabidiol (CBD) Personal Care & Cosmetics , by Region USD Million (2015-2020)
  • Table 3. Cannabidiol (CBD) Pharmaceutical , by Region USD Million (2015-2020)
  • Table 4. Cannabidiol (CBD) Food & Beverages , by Region USD Million (2015-2020)
  • Table 5. Cannabidiol (CBD) Others , by Region USD Million (2015-2020)
  • Table 6. Cannabidiol (CBD): by Distribution Channel(USD Million)
  • Table 7. Cannabidiol (CBD) Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 8. Cannabidiol (CBD) Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 9. Cannabidiol (CBD) Online Stores , by Region USD Million (2015-2020)
  • Table 10. Cannabidiol (CBD) Others , by Region USD Million (2015-2020)
  • Table 11. Cannabidiol (CBD): by Product(USD Million)
  • Table 12. Cannabidiol (CBD) Cannabis Balm , by Region USD Million (2015-2020)
  • Table 13. Cannabidiol (CBD) Cannabis Cream , by Region USD Million (2015-2020)
  • Table 14. Cannabidiol (CBD) Cannabis Oil , by Region USD Million (2015-2020)
  • Table 15. Cannabidiol (CBD) Cannabis Oil Capsules , by Region USD Million (2015-2020)
  • Table 16. Cannabidiol (CBD) Others , by Region USD Million (2015-2020)
  • Table 17. Cannabidiol (CBD): by Source(USD Million)
  • Table 18. Cannabidiol (CBD) Hemp , by Region USD Million (2015-2020)
  • Table 19. Cannabidiol (CBD) Marijuana , by Region USD Million (2015-2020)
  • Table 20. MEA Cannabidiol (CBD), by Country USD Million (2015-2020)
  • Table 21. MEA Cannabidiol (CBD), by Application USD Million (2015-2020)
  • Table 22. MEA Cannabidiol (CBD), by Distribution Channel USD Million (2015-2020)
  • Table 23. MEA Cannabidiol (CBD), by Product USD Million (2015-2020)
  • Table 24. MEA Cannabidiol (CBD), by Source USD Million (2015-2020)
  • Table 25. South Africa Cannabidiol (CBD), by Application USD Million (2015-2020)
  • Table 26. South Africa Cannabidiol (CBD), by Distribution Channel USD Million (2015-2020)
  • Table 27. South Africa Cannabidiol (CBD), by Product USD Million (2015-2020)
  • Table 28. South Africa Cannabidiol (CBD), by Source USD Million (2015-2020)
  • Table 29. Cannabidiol (CBD) Sales: by Application(K Units)
  • Table 30. Cannabidiol (CBD) Sales Personal Care & Cosmetics , by Region K Units (2015-2020)
  • Table 31. Cannabidiol (CBD) Sales Pharmaceutical , by Region K Units (2015-2020)
  • Table 32. Cannabidiol (CBD) Sales Food & Beverages , by Region K Units (2015-2020)
  • Table 33. Cannabidiol (CBD) Sales Others , by Region K Units (2015-2020)
  • Table 34. Cannabidiol (CBD) Sales: by Distribution Channel(K Units)
  • Table 35. Cannabidiol (CBD) Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 36. Cannabidiol (CBD) Sales Retail Pharmacies , by Region K Units (2015-2020)
  • Table 37. Cannabidiol (CBD) Sales Online Stores , by Region K Units (2015-2020)
  • Table 38. Cannabidiol (CBD) Sales Others , by Region K Units (2015-2020)
  • Table 39. Cannabidiol (CBD) Sales: by Product(K Units)
  • Table 40. Cannabidiol (CBD) Sales Cannabis Balm , by Region K Units (2015-2020)
  • Table 41. Cannabidiol (CBD) Sales Cannabis Cream , by Region K Units (2015-2020)
  • Table 42. Cannabidiol (CBD) Sales Cannabis Oil , by Region K Units (2015-2020)
  • Table 43. Cannabidiol (CBD) Sales Cannabis Oil Capsules , by Region K Units (2015-2020)
  • Table 44. Cannabidiol (CBD) Sales Others , by Region K Units (2015-2020)
  • Table 45. Cannabidiol (CBD) Sales: by Source(K Units)
  • Table 46. Cannabidiol (CBD) Sales Hemp , by Region K Units (2015-2020)
  • Table 47. Cannabidiol (CBD) Sales Marijuana , by Region K Units (2015-2020)
  • Table 48. MEA Cannabidiol (CBD) Sales, by Country K Units (2015-2020)
  • Table 49. MEA Cannabidiol (CBD) Sales, by Application K Units (2015-2020)
  • Table 50. MEA Cannabidiol (CBD) Sales, by Distribution Channel K Units (2015-2020)
  • Table 51. MEA Cannabidiol (CBD) Sales, by Product K Units (2015-2020)
  • Table 52. MEA Cannabidiol (CBD) Sales, by Source K Units (2015-2020)
  • Table 53. South Africa Cannabidiol (CBD) Sales, by Application K Units (2015-2020)
  • Table 54. South Africa Cannabidiol (CBD) Sales, by Distribution Channel K Units (2015-2020)
  • Table 55. South Africa Cannabidiol (CBD) Sales, by Product K Units (2015-2020)
  • Table 56. South Africa Cannabidiol (CBD) Sales, by Source K Units (2015-2020)
  • Table 57. Company Basic Information, Sales Area and Its Competitors
  • Table 58. Company Basic Information, Sales Area and Its Competitors
  • Table 59. Company Basic Information, Sales Area and Its Competitors
  • Table 60. Company Basic Information, Sales Area and Its Competitors
  • Table 61. Company Basic Information, Sales Area and Its Competitors
  • Table 62. Company Basic Information, Sales Area and Its Competitors
  • Table 63. Company Basic Information, Sales Area and Its Competitors
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Cannabidiol (CBD): by Application(USD Million)
  • Table 68. Cannabidiol (CBD) Personal Care & Cosmetics , by Region USD Million (2021-2026)
  • Table 69. Cannabidiol (CBD) Pharmaceutical , by Region USD Million (2021-2026)
  • Table 70. Cannabidiol (CBD) Food & Beverages , by Region USD Million (2021-2026)
  • Table 71. Cannabidiol (CBD) Others , by Region USD Million (2021-2026)
  • Table 72. Cannabidiol (CBD): by Distribution Channel(USD Million)
  • Table 73. Cannabidiol (CBD) Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 74. Cannabidiol (CBD) Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 75. Cannabidiol (CBD) Online Stores , by Region USD Million (2021-2026)
  • Table 76. Cannabidiol (CBD) Others , by Region USD Million (2021-2026)
  • Table 77. Cannabidiol (CBD): by Product(USD Million)
  • Table 78. Cannabidiol (CBD) Cannabis Balm , by Region USD Million (2021-2026)
  • Table 79. Cannabidiol (CBD) Cannabis Cream , by Region USD Million (2021-2026)
  • Table 80. Cannabidiol (CBD) Cannabis Oil , by Region USD Million (2021-2026)
  • Table 81. Cannabidiol (CBD) Cannabis Oil Capsules , by Region USD Million (2021-2026)
  • Table 82. Cannabidiol (CBD) Others , by Region USD Million (2021-2026)
  • Table 83. Cannabidiol (CBD): by Source(USD Million)
  • Table 84. Cannabidiol (CBD) Hemp , by Region USD Million (2021-2026)
  • Table 85. Cannabidiol (CBD) Marijuana , by Region USD Million (2021-2026)
  • Table 86. MEA Cannabidiol (CBD), by Country USD Million (2021-2026)
  • Table 87. MEA Cannabidiol (CBD), by Application USD Million (2021-2026)
  • Table 88. MEA Cannabidiol (CBD), by Distribution Channel USD Million (2021-2026)
  • Table 89. MEA Cannabidiol (CBD), by Product USD Million (2021-2026)
  • Table 90. MEA Cannabidiol (CBD), by Source USD Million (2021-2026)
  • Table 91. South Africa Cannabidiol (CBD), by Application USD Million (2021-2026)
  • Table 92. South Africa Cannabidiol (CBD), by Distribution Channel USD Million (2021-2026)
  • Table 93. South Africa Cannabidiol (CBD), by Product USD Million (2021-2026)
  • Table 94. South Africa Cannabidiol (CBD), by Source USD Million (2021-2026)
  • Table 95. Cannabidiol (CBD) Sales: by Application(K Units)
  • Table 96. Cannabidiol (CBD) Sales Personal Care & Cosmetics , by Region K Units (2021-2026)
  • Table 97. Cannabidiol (CBD) Sales Pharmaceutical , by Region K Units (2021-2026)
  • Table 98. Cannabidiol (CBD) Sales Food & Beverages , by Region K Units (2021-2026)
  • Table 99. Cannabidiol (CBD) Sales Others , by Region K Units (2021-2026)
  • Table 100. Cannabidiol (CBD) Sales: by Distribution Channel(K Units)
  • Table 101. Cannabidiol (CBD) Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 102. Cannabidiol (CBD) Sales Retail Pharmacies , by Region K Units (2021-2026)
  • Table 103. Cannabidiol (CBD) Sales Online Stores , by Region K Units (2021-2026)
  • Table 104. Cannabidiol (CBD) Sales Others , by Region K Units (2021-2026)
  • Table 105. Cannabidiol (CBD) Sales: by Product(K Units)
  • Table 106. Cannabidiol (CBD) Sales Cannabis Balm , by Region K Units (2021-2026)
  • Table 107. Cannabidiol (CBD) Sales Cannabis Cream , by Region K Units (2021-2026)
  • Table 108. Cannabidiol (CBD) Sales Cannabis Oil , by Region K Units (2021-2026)
  • Table 109. Cannabidiol (CBD) Sales Cannabis Oil Capsules , by Region K Units (2021-2026)
  • Table 110. Cannabidiol (CBD) Sales Others , by Region K Units (2021-2026)
  • Table 111. Cannabidiol (CBD) Sales: by Source(K Units)
  • Table 112. Cannabidiol (CBD) Sales Hemp , by Region K Units (2021-2026)
  • Table 113. Cannabidiol (CBD) Sales Marijuana , by Region K Units (2021-2026)
  • Table 114. MEA Cannabidiol (CBD) Sales, by Country K Units (2021-2026)
  • Table 115. MEA Cannabidiol (CBD) Sales, by Application K Units (2021-2026)
  • Table 116. MEA Cannabidiol (CBD) Sales, by Distribution Channel K Units (2021-2026)
  • Table 117. MEA Cannabidiol (CBD) Sales, by Product K Units (2021-2026)
  • Table 118. MEA Cannabidiol (CBD) Sales, by Source K Units (2021-2026)
  • Table 119. South Africa Cannabidiol (CBD) Sales, by Application K Units (2021-2026)
  • Table 120. South Africa Cannabidiol (CBD) Sales, by Distribution Channel K Units (2021-2026)
  • Table 121. South Africa Cannabidiol (CBD) Sales, by Product K Units (2021-2026)
  • Table 122. South Africa Cannabidiol (CBD) Sales, by Source K Units (2021-2026)
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. MEA Cannabidiol (CBD): by Application USD Million (2015-2020)
  • Figure 5. MEA Cannabidiol (CBD): by Distribution Channel USD Million (2015-2020)
  • Figure 6. MEA Cannabidiol (CBD): by Product USD Million (2015-2020)
  • Figure 7. MEA Cannabidiol (CBD): by Source USD Million (2015-2020)
  • Figure 8. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 9. MEA Cannabidiol (CBD): by Application K Units (2015-2020)
  • Figure 10. MEA Cannabidiol (CBD): by Distribution Channel K Units (2015-2020)
  • Figure 11. MEA Cannabidiol (CBD): by Product K Units (2015-2020)
  • Figure 12. MEA Cannabidiol (CBD): by Source K Units (2015-2020)
  • Figure 13. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 14. MEA Cannabidiol (CBD) share by Players 2020 (%)
  • Figure 15. MEA Cannabidiol (CBD) share by Players (Top 3) 2020(%)
  • Figure 16. MEA Cannabidiol (CBD) share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Canopy Growth Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 19. Canopy Growth Corporation (Canada) Revenue: by Geography 2020
  • Figure 20. Elixinol (United States) Revenue, Net Income and Gross profit
  • Figure 21. Elixinol (United States) Revenue: by Geography 2020
  • Figure 22. Aphria, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Aphria, Inc. (Canada) Revenue: by Geography 2020
  • Figure 24. CannaLife (South Africa) Revenue, Net Income and Gross profit
  • Figure 25. CannaLife (South Africa) Revenue: by Geography 2020
  • Figure 26. BIOMUTI (Pty) Ltd (South Africa) Revenue, Net Income and Gross profit
  • Figure 27. BIOMUTI (Pty) Ltd (South Africa) Revenue: by Geography 2020
  • Figure 28. NuLeaf Naturals, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. NuLeaf Naturals, LLC (United States) Revenue: by Geography 2020
  • Figure 30. Oil Science (South Africa) Revenue, Net Income and Gross profit
  • Figure 31. Oil Science (South Africa) Revenue: by Geography 2020
  • Figure 32. Cannaza (South Africa) Revenue, Net Income and Gross profit
  • Figure 33. Cannaza (South Africa) Revenue: by Geography 2020
  • Figure 34. CBD Biotechnologies (South Africa) Revenue, Net Income and Gross profit
  • Figure 35. CBD Biotechnologies (South Africa) Revenue: by Geography 2020
  • Figure 36. King CBD (South Africa) Revenue, Net Income and Gross profit
  • Figure 37. King CBD (South Africa) Revenue: by Geography 2020
  • Figure 38. MEA Cannabidiol (CBD): by Application USD Million (2021-2026)
  • Figure 39. MEA Cannabidiol (CBD): by Distribution Channel USD Million (2021-2026)
  • Figure 40. MEA Cannabidiol (CBD): by Product USD Million (2021-2026)
  • Figure 41. MEA Cannabidiol (CBD): by Source USD Million (2021-2026)
  • Figure 42. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 43. MEA Cannabidiol (CBD): by Application K Units (2021-2026)
  • Figure 44. MEA Cannabidiol (CBD): by Distribution Channel K Units (2021-2026)
  • Figure 45. MEA Cannabidiol (CBD): by Product K Units (2021-2026)
  • Figure 46. MEA Cannabidiol (CBD): by Source K Units (2021-2026)
  • Figure 47. MEA Cannabidiol (CBD) Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Canopy Growth Corporation (Canada)
  • Elixinol (United States)
  • Aphria, Inc. (Canada)
  • CannaLife (South Africa)
  • BIOMUTI (Pty) Ltd (South Africa)
  • NuLeaf Naturals, LLC (United States)
  • Oil Science (South Africa)
  • Cannaza (South Africa)
  • CBD Biotechnologies (South Africa)
  • King CBD (South Africa)
Select User Access Type

Key Highlights of Report


Jan 2022 217 Pages 71 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cannabidiol (CBD) Quantitative research analysis
Global Cannabidiol (CBD) Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The MEA Cannabidiol (CBD) market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of MEA Cannabidiol (CBD) market are Canopy Growth Corporation (Canada), Elixinol (United States), Aphria, Inc. (Canada), CannaLife (South Africa), BIOMUTI (Pty) Ltd (South Africa), NuLeaf Naturals, LLC (United States), Oil Science (South Africa), Cannaza (South Africa), CBD Biotechnologies (South Africa) and King CBD (South Africa), to name a few.
In this highly competitive & fast evolving Cannabidiol (CBD) industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Cannabidiol (CBD) Report?

Have a Query? Click Here

Other Related Reports

Retinal Drugs Comprehensive Study by Type (Wet AMD, Diabetic Retinopathy, DME, RVO, Mcnv), Prescription Type (Prescription Ophthalmic Drugs, OTC), Distribution Channel (Hospital Pharmacies, Drug Stor...
$ 3350
Veterinary Medicine Comprehensive Study by Type (Pharmaceuticals, Vaccines, Others), Application (Companion Animals, Farm Animals), Distribution Channel (Online, Offline), End User (Veterinary Clinic...
$ 3800
Tretinoin Drugs Comprehensive Study by Type (Oral, Injection), Application (Keratinization Disorders, Acute Promyelocytic Leukemia (APL), Others), End-users (Hospitals, Clinics, Others), Distribution...
$ 3350
Patent Medicine Comprehensive Study by Type (Product Patents, Process Patents), Application (Adult, Children), Drug Type (Solid Drug, Semi-Solid Drug, Liquid Drug, Gas/Aerosol Drug, Others), Disease ...
$ 3750
Over The Counter (OTC) Drugs Comprehensive Study by Type (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalm...
$ 3750
Intravenous (IV) Ibuprofen Comprehensive Study by Application (Pediatrics, Adults), Indication (Pain/Inflammatory, Fever), Form (Tablet, Capsule, Suspension, Other) Players and Region - Global Market...
$ 3500